Related Experiment Video
Updated: Jul 8, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven
Igor Goryanin1, Irina Goryanin2
1University of Edinburgh, Edinburgh, UK; IQANOVA Ltd, Edinburgh, UK.
Abstract:
Quantitative systems pharmacology (QSP) models support model-informed drug development but are computationally expensive, limiting workflows requiring many simulations. Artificial intelligence (AI)-enabled surrogates can accelerate these workflows, but require validation aligned with context of use and regulatory expectations. Here, we present an eight-step validation framework covering simulation-campaign design, baseline comparison, endpoint accuracy, trajectory fidelity, uncertainty calibration, distributional agreement, biological plausibility, and computational efficiency. The framework is illustrated through chimeric antigen receptor T cell (CAR-T) immunotherapy and hybrid neural ordinary differential equation (ODE) erythropoiesis examples and aligned with ICH M15 and ASME V&V40. Supplementary algorithms provide practical validation recipes.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Quantitative Aspects of Drug-Receptor Interaction
Mechanistic Models: Overview of Compartment Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
